A Study to Explore Ghrelin Levels with Primary Graft Dysfunction in Lung Transplant Recipients


About this study

The purpose of this study is to investigate ghrelin, a peptide that mechanistically carries the promise of therapeutics benefit for diverse aspects of morbidity associated with lung transplantation.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • All patients who will undergo single or double lung transplant at Mayo Clinic Florida.

Exclusion Criteria:

  • Patients who do not survive the intra-operative period during the transplant surgery.
  • Patients undergoing re-transplantation.
  • Patients undergoing multi-organ transplantation.
  • Patients who do not give written consent would be excluded from the study.


Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Jacksonville, Fla.

Mayo Clinic principal investigator

Tathagat Narula, M.B.B.S., M.D.

Open for enrollment

Contact information:

Robert Brannock B.S.



More information


Publications are currently not available

Study Results Summary

Not yet available

Supplemental Study Information

Not yet available


Mayo Clinic Footer